CYCLO THERAPEUTICS, INC. Retained Earnings
CYCLO THERAPEUTICS, INC. had Retained Earnings of -$103.01 million as of 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2024-12-18
- 2024-09-30: Retained Earnings (Accumulated Deficit) -$103.01M.
- 2024-06-30: Retained Earnings (Accumulated Deficit) -$94.18M.
- 2024-03-31: Retained Earnings (Accumulated Deficit) -$88.20M.
- 2023-12-31: Retained Earnings (Accumulated Deficit) -$83.86M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2024-09-30 | -$103.01M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | -$94.18M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | -$88.20M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | -$83.86M 10-K/A · filed 2024-12-18 | |
| 2023-09-30 | -$78.21M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | -$73.44M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | -$68.81M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | -$63.80M 10-K/A · filed 2024-12-18 | |
| 2022-09-30 | -$58.82M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | -$54.57M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | -$51.12M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | -$48.35M 10-K · filed 2023-03-17 | |
| 2021-09-30 | -$45.56M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | -$41.70M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | -$38.10M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | -$34.06M 10-K · filed 2022-03-11 | |
| 2020-09-30 | -$31.38M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | -$29.95M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | -$27.75M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | -$25.12M 10-K · filed 2021-03-12 | |
| 2019-09-30 | -$22.49M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | -$20.86M 10-Q · filed 2019-08-13 | |
| 2019-03-31 | -$19.49M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | -$17.59M 10-K · filed 2020-03-30 | |
| 2018-09-30 | -$16.22M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | -$15.43M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | -$14.15M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | -$13.33M 10-K · filed 2019-03-15 | |
| 2017-09-30 | -$11.95M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | -$11.31M 10-Q · filed 2017-08-11 | |
| 2017-03-31 | -$10.49M 10-Q · filed 2017-05-12 | |
| 2016-12-31 | -$9.50M 10-K · filed 2018-04-16 | |
| 2016-09-30 | -$8.67M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | -$7.05M 10-Q · filed 2016-08-12 | |
| 2016-03-31 | -$5.98M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | -$5.28M 10-K · filed 2017-03-17 | |
| 2015-09-30 | -$4.22M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | -$3.47M 10-Q · filed 2015-08-14 | |
| 2015-03-31 | -$3.11M 10-Q · filed 2015-05-15 | |
| 2014-12-31 | -$2.72M 10-K · filed 2016-03-30 | |
| 2014-09-30 | -$2.41M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | -$2.19M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | -$2.03M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | -$2.13M 10-K · filed 2015-03-27 | |
| 2013-09-30 | -$2.05M 10-Q · filed 2013-11-13 | |
| 2013-06-30 | -$1.95M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | -$2.22M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | -$2.34M 10-K · filed 2014-03-04 | |
| 2012-09-30 | -$2.47M 10-Q · filed 2012-11-13 | |
| 2012-06-30 | -$2.42M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | -$2.37M 10-Q · filed 2012-05-21 | |
| 2011-12-31 | -$2.41M 10-K · filed 2013-03-14 | |
| 2011-09-30 | -$2.34M 10-Q/A · filed 2012-02-23 | -$2.27M 10-Q · filed 2011-11-18 |
| 2011-06-30 | -$2.29M 10-Q · filed 2011-08-15 | |
| 2010-12-31 | -$2.31M 10-K · filed 2012-03-16 |